Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Filovirus Infections”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05202288
What this trial is testing

Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 132
Testing effectiveness (Phase 2)Study completedNCT02598388
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 578
Not applicableStudy completedNCT04409405
What this trial is testing

Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)

Who this might be right for
Ebola Virus Disease
Institut National de la Santé Et de la Recherche Médicale, France 787
Testing effectiveness (Phase 2)Study completedNCT05064956
What this trial is testing

Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)

Who this might be right for
Ebola Virus DiseaseEbolaHiv
London School of Hygiene and Tropical Medicine 26
Early research (Phase 1)Study completedNCT01566877
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers

Who this might be right for
Marburg Hemorrhagic Fever
Sarepta Therapeutics, Inc. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06100913
What this trial is testing

Immunology of Ebola Vaccine

Who this might be right for
Ebola Virus Disease
Emory University 30
Early research (Phase 1)UnknownNCT05301504
What this trial is testing

A Study in Tanzania of a New Vaccine Against Two Types of Ebola

Who this might be right for
Ebola
University of Oxford 76
Early research (Phase 1)Study completedNCT02326194
What this trial is testing

A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.

Who this might be right for
Ebola Virus Disease
Jiangsu Province Centers for Disease Control and Prevention 120
Early research (Phase 1)Study completedNCT06265012
What this trial is testing

Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects

Who this might be right for
Marburg Virus Disease
Public Health Vaccines LLC 36
Not applicableUnknownNCT04235361
What this trial is testing

Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC

Who this might be right for
Ebola Virus DiseaseMalariaTyphoid Fever+3 more
University of Stirling 500
Testing effectiveness (Phase 2)Study completedNCT05130398
What this trial is testing

Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon

Who this might be right for
Ebola Virus Disease
Centre de Recherche Médicale de Lambaréné 120
Early research (Phase 1)Looking for participantsNCT07425821
What this trial is testing

A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health

Who this might be right for
Marburg Virus Disease
International AIDS Vaccine Initiative 112
Early research (Phase 1)Ended earlyNCT02451891
What this trial is testing

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

Who this might be right for
Ebola Virus Disease
University of Oxford 38
Not applicableEnded earlyNCT04250168
What this trial is testing

Piloting Clinical Bacteriology in the Ebola Virus Disease Care Response

Who this might be right for
Sepsis BacterialEbola Virus DiseaseBloodstream Infection
Institute of Tropical Medicine, Belgium 43
Early research (Phase 1)Study completedNCT02495246
What this trial is testing

Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV

Who this might be right for
Ebola Virus Disease
University of Oxford 32
Early research (Phase 1)Study completedNCT00997607
What this trial is testing

Evaluating an Ebola and a Marburg Vaccine in Uganda

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT06620003
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
Albert B. Sabin Vaccine Institute 200
Early research (Phase 1)Study completedNCT02267109
What this trial is testing

Phase 1 Trial of Ebola Vaccine in Mali

Who this might be right for
Ebola Virus DiseaseHemorrhagic Fever
University of Maryland, Baltimore 91
Early research (Phase 1)WithdrawnNCT01593072
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc.
Early research (Phase 1)Ended earlyNCT03462004
What this trial is testing

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 15
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation